Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Tuesday, August 6, 2019, at 8:30 a.m. ET to review its second quarter 2019 financial results and provide an update on the company.
A live webcast of the conference call can be accessed in the “Investors” section of Gamida Cell’s website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (domestic) or 409-216-0605 (international) and refer to conference ID number 2127937. A replay of the webcast will be available for approximately 30 days.
About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion technology to develop product candidates designed to address the limitations of cell therapies. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190723005075/en/
Contacts
Jaren Irene Madden
jaren@gamida-cell.com
617-892-9084
Krystle Gibbs (media)
krystle@tenbridgecommunications.com
508-479-6358
Source: Gamida Cell
View this news release online at:
http://www.businesswire.com/news/home/20190723005075/en
